{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:02:11Z","timestamp":1773284531327,"version":"3.50.1"},"reference-count":71,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1586\/14787210.5.3.393","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T14:00:21Z","timestamp":1180965621000},"page":"393-401","source":"Crossref","is-referenced-by-count":34,"title":["Vancomycin: does it still have a role as an antistaphylococcal agent?"],"prefix":"10.1586","volume":"5","author":[{"given":"Stan","family":"Deresinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L","volume":"83","author":"Elting","year":"1998","journal-title":"Cancer"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","volume":"1","author":"Jevons","year":"1961","journal-title":"Br. Med. J."},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","volume":"1","author":"Uttley","year":"1988","journal-title":"Lancet"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","volume":"34","author":"Small","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01402.x","volume":"12","author":"Appelbaum","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01388-06"},{"key":"CIT0008","unstructured":"Kapadia M, Coyle E, Prince Ret al.Decliningin vitroactivity of vancomycin againstStaphylococcus aureusisolates from cancer patients. Presented at:45th Interscience Conference on Antimicrobial Agents and Chemotherapy,Washington DC, USA, December 16\u201319, 2005 (Abstract E-807)."},{"key":"CIT0009","unstructured":"Golan Y, Baiez-Giangreco C, O\u2019Sullivan C, Snydman DR. Trends in vancomycin susceptibility among consecutive MRSA bacteremia isolates.Presented at: 44th Annual Meeting of the Infectious Disease Society of America,October 12\u201315, Toronto, Canada, 2006, Abstract LB-11."},{"key":"CIT0010","unstructured":"Huang V, Tenover FC, McGowan JE Jr. DetectingStaphylococcus aureusisolates with reduced vancomycin susceptibility.46th Interscience Conference on Antimicrobial Agents and Chemotherapy,September 27\u201330, CA, USA, 2006 (Abstract D-811)."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4665-4672.2004"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10096-005-0011-0","volume":"24","author":"Ekdahl","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3040-3045.2003"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/342708","volume":"186","author":"Hussain","year":"2002","journal-title":"J. Infect. Dis."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00422-06"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1086\/381093"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jac\/dkl355","volume":"58","author":"Fern\u00e1ndez Guerrero","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/AAC.47.1.398-399.2003","volume":"47","author":"Gunderson","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/AAC.36.12.2709","volume":"36","author":"Lamp","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.4.589"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/AAC.50.1.55-61.2006","volume":"50","author":"Saginur","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/jac\/dki106","volume":"55","author":"Wiederhold","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7883\/yoken.JJID.2005.353","volume":"58","author":"Mathur","year":"2005","journal-title":"Jpn J. Infect. Dis."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/42.2.189","volume":"42","author":"May","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cncr.21801","volume":"106","author":"Safdar","year":"2006","journal-title":"Cancer"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.6.2398-2402.2004"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/AAC.50.2.527-533.2006","volume":"50","author":"Sieradzki","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1581-1585.2006"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.1079-1082.2006"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/106002808802200404","volume":"22","author":"Ackerman","year":"1988","journal-title":"Drug Intell. Clin. Pharm."},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AAC.37.5.1132","volume":"37","author":"Sun","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1372-1375.2006"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.46.5.1475-1480.2002","volume":"46","author":"Lamer","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"CIT0036","unstructured":"Craig WA, Andes DR.In vivopharmacodynamics of vancomycin against VISA, heteroresistant VISA and VSSA in the neutropenic murine thigh-infection model.Presented at: 46th Interscience Conference on Antimicrobial Agents and Chemotherapy,September 27\u201330, CA, USA, 2006 (Abstract A-644)."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","year":"2005","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.130.4.947","volume":"130","author":"Jeffres","year":"2006","journal-title":"Chest"},{"key":"CIT0039","unstructured":"Hidayat L, Hsu D, Shriner K, Wong-Beringer A. Outcomes of vancomycin-treated methicillin-resistantStaphylococcus aureusinfections targeting higher trough concentration. Presented at:43rdAnnual Meeting of the Infectious Disease Society of America,October 6\u20139, CA, USA, 2005 (Abstract 352)."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/502268","volume":"24","author":"Bernard","year":"2003","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"CIT0041","unstructured":"Lee-Such SC, Overholser BR, Munoz-Price LS. Nephrotoxicity associated with aggressive vancomycin therapy.46th ICAAC.September 27\u201330, CA, USA, 2006, Abstract L-1298."},{"key":"CIT0042","unstructured":"Jeffres MN, Micek ST, Isakow Wet al.Increased incidence of nephrotoxicity with higher vancomycin serum trough concentrations. Presented at:46th Interscience Conference on Antimicrobial Agents and Chemotherapy,September 27\u201330, CA, USA, 2006 (Abstract K-789)."},{"key":"CIT0043","unstructured":"McKinnon PS, Lodise TP Jr, Tybak MJ. Impact of initial treatment with vancomycin versus a \u03b2-lactam and costs of methicillin-susceptibleStaphylococcus aureusbacteremia. Presented at:40th Annual Meeting of the Infectious Disease Society of America.October 24\u201327, IL, USA, 2002 (Abstract 579)."},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.862-867.2006"},{"key":"CIT0046","unstructured":"Corey R. ATLAS: televancin in cSSSI, a landmark trial for MRSA. Presented at:3rd International Symposium on Resistant Gram-Positive Infections.Ontario, Canada, October 9\u201311, 2006."},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2260-2266.2005"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.amjsurg.2005.01.011","volume":"189","author":"Sharpe","year":"2005","journal-title":"Am. J. Surg."},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjsurg.2004.08.045","volume":"188","author":"Weigelt","year":"2004","journal-title":"Am. J. Surg."},{"key":"CIT0050","unstructured":"Goldstein BP, Seltzer E, Flamm R, Sahm D. Dalbavancin phase 3 skin and skin structure studies: pathogens and microbiological efficacy. Presented at:45th Interscience Conference on Antimicrobial Agents and Chemotherapy.Washington DC, December 16\u201319, 2005 (Abstract L-1577)."},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00134-003-2088-1","volume":"30","author":"Kollef","year":"2004","journal-title":"Intensive Care Med."},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","volume":"115","author":"Levine","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"CIT0054","unstructured":"Cosgrove S, Fowler V, Boucher Het al.Initial low-dose gentamicin in the treatment ofS. aureusbacteremia and endocarditis is nephrotoxic. Presented at:44thAnnual Meeting of the Infectious Disease Society of America.October 12\u201315, Toronto, Canada, 2006 (Abstract 371)."},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1086\/498977","volume":"42","author":"Jones","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/429906","volume":"40","author":"Eguia","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijantimicag.2005.10.009","volume":"27","author":"Kleinschmidt","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/AAC.44.2.294-303.2000","volume":"44","author":"Pfeltz","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0059","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.00073-06","volume":"50","author":"McCallum","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0060","unstructured":"Lee S, Cho Y, Kwon Het al.Biological effect of vancomycin resistance inStaphylococus aureus.Presented at:46th Interscience Conference on Antimicrobial Agents and Chemotherapy.September 27\u201330, CA, USA, 2006 (Abstract C1\u20131826)."},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/425009","volume":"39","author":"Finberg","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"CIT0063","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/504431","volume":"42","author":"Tattevin","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"CIT0064","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dki355","volume":"56","author":"Shorr","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1378\/chest.126.1.314","volume":"126","author":"Powers","year":"2004","journal-title":"Chest"},{"key":"CIT0066","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"Fowler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"CIT0067","unstructured":"Noel GJ, Strauss RS, Pypstra R; 00154 Study Group. Successful treatment of complicated skin infections due to staphylococci, including methicillin-resistantStaphylococcus aureuswith ceftibiprole. Presented at:46th Interscience Conference on Antimicrobial Agents and Chemotherapy.September 27\u201330, CA, USA, 2006 (Abstract L-1212)."},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1086\/431675"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1086\/420818"},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/427701","volume":"40","author":"Deresinski","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2165\/00003495-200666140-00002","volume":"66","author":"Deresinski","year":"2006","journal-title":"Drugs"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14787210.5.3.393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:36:58Z","timestamp":1707939418000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14787210.5.3.393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1586\/14787210.5.3.393"],"URL":"https:\/\/doi.org\/10.1586\/14787210.5.3.393","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}